Related Experiment Video
Updated: May 9, 2025

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
Unveiling Cellular Responses and Underlying Immune Effects Induced by Boron Neutron Capture Therapy.
Hongyuan Mao1, Jinyue Li1, Chenhan Huang1
1Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, China.
Boron neutron capture therapy (BNCT) offers a novel cancer treatment approach. BNCT shows enhanced immunogenicity compared to traditional radiation, suggesting potent combination therapy with immunotherapy for advanced cancer treatment.
Area of Science:
- Oncology
- Radiation Biology
- Immunotherapy
Background:
- Boron neutron capture therapy (BNCT) is an emerging cancer treatment modality with slow progress due to technological limitations.
- Recent advancements in neutron sources and boron compounds have revitalized research in BNCT's radiobiological effects.
- A comprehensive review is needed to understand the current status and potential of BNCT.
Purpose of the Study:
- To provide a detailed description of BNCT's mechanisms of cell killing and cellular responses.
- To explore the immunologic potential of BNCT and its synergy with immunotherapy.
- To establish a theoretical foundation for future clinical applications of BNCT.
Main Methods:
- Systematic review integrating the latest research findings on BNCT.
- Analysis of direct and indirect mechanisms of BNCT-induced cell death.
- Evaluation of cellular responses to BNCT and its immunogenic properties.
Main Results:
- BNCT utilizes specific mechanisms to induce cancer cell killing.
- BNCT demonstrates a stronger immunologic foundation and immunogenicity than conventional radiation therapy.
- Significant potential exists for combining BNCT with immunotherapy.
Conclusions:
- BNCT offers a promising approach for cancer treatment with unique radiobiological effects.
- The immunogenic nature of BNCT supports its combination with immunotherapy for enhanced efficacy.
- Further investigation into BNCT combined with immunotherapy may lead to advanced cancer treatment strategies.
More Related Videos
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
05:39Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Biological Effects of Radiation
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...